LON:BVXP Bioventix (BVXP) Share Price, News & Analysis GBX 2,878 -17.00 (-0.59%) As of 11:47 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Bioventix Stock (LON:BVXP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bioventix alerts:Sign Up Key Stats Today's Range 2,800▼ 2,89050-Day Range 2,370▼ 2,89552-Week Range 2,200▼ 4,550Volume5,484 shsAverage Volume8,342 shsMarket Capitalization£150.70 millionP/E Ratio18.61Dividend Yield5.49%Price TargetN/AConsensus RatingN/A Company OverviewBioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.Read More… Receive BVXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter. Email Address BVXP Stock News HeadlinesBruce Hiscock Buys 31 Shares of Bioventix PLC (LON:BVXP) StockApril 29, 2025 | insidertrades.comShareholders in Bioventix (LON:BVXP) are in the red if they invested a year agoMay 6, 2025 | finance.yahoo.comElon Musk’s Next Big BetCancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.May 12, 2025 | Banyan Hill Publishing (Ad)5 AIM stocks to consider buying for the long termApril 24, 2025 | msn.com3 UK Dividend Stocks Offering Yields Up To 7.2%April 8, 2025 | finance.yahoo.com3 top AIM stocks to consider buying before they recoverMarch 19, 2025 | uk.finance.yahoo.comWith 62% ownership, Bioventix PLC (LON:BVXP) boasts of strong institutional backingFebruary 9, 2025 | finance.yahoo.comWill the stock market rise in 2025, and how high could it go?December 14, 2024 | msn.comSee More Headlines BVXP Stock Analysis - Frequently Asked Questions How have BVXP shares performed this year? Bioventix's stock was trading at GBX 3,240 on January 1st, 2025. Since then, BVXP shares have decreased by 11.2% and is now trading at GBX 2,878. View the best growth stocks for 2025 here. How were Bioventix's earnings last quarter? Bioventix PLC (LON:BVXP) announced its earnings results on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share for the quarter. Bioventix had a net margin of 59.51% and a trailing twelve-month return on equity of 69.09%. How do I buy shares of Bioventix? Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Bioventix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON). Company Calendar Last Earnings3/31/2025Record date for 4/25 Dividend4/10/2025Ex-Dividend for 4/25 Dividend4/10/2025Dividend Payable4/25/2025Today5/12/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryCannabis Current SymbolLON:BVXP CIKN/A Webwww.bioventix.com Phone+44-1252-728001FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 154.62 Trailing P/E Ratio18.72 Forward P/E RatioN/A P/E GrowthN/ANet Income£8.12 million Net Margins59.51% Pretax MarginN/A Return on Equity69.09% Return on Assets54.07% Debt Debt-to-Equity RatioN/A Current Ratio7.42 Quick Ratio5.50 Sales & Book Value Annual Sales£13.65 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow30.89 Book ValueGBX 229.94 per share Price / BookN/AMiscellaneous Outstanding Shares5,236,318Free FloatN/AMarket Cap£151.59 million OptionableNot Optionable Beta0.35 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (LON:BVXP) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredVIDEO: Strange New Elon Device to Shock the WorldElon Musk’s Next BIG Bet And this time he plans to dominate a market worth $3.2 trillion. That’s why I’m...Banyan Hill Publishing | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThis picture could hold the secret to the market's next move.A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.